Orocidin A/S
CVR 44348845 · Public limited company (A/S) · Active · High risk
Orocidin A/S is a Public limited company (A/S), founded on , based in Søborg. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 3.4% over the next 12 months, which is 2.4 times the average for Danish companies. 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK 10.0m and a net result of DKK -539k. CEO: Allan Traugott Wehnert.
Bankruptcy risk for Orocidin A/S
2.4 × the average (1.41%) · higher risk than 88% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44348845
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (3 years)
- Address
- Vandtårnsvej 62A, 1. b
2860 Søborg - Municipality
- Gladsaxe
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 568k
- Auditor
- CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 66.3% |
| Current ratio | 10% |
| Moves (last 2 years) | 2 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 119 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 |
|---|---|---|
| Gross profit | DKK -706k | DKK -1.4m |
| Net profit | DKK -539k | DKK -1.4m |
| Equity | DKK 10.0m | DKK 2.9m |
| Total assets | DKK 15.0m | DKK 9.3m |
| Cash | DKK 24k | – |
| Short-term debt | DKK 5.1m | DKK 6.4m |
| Avg. employees | 0 | 1 |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Crowe.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 184 | Late | |
| 2 Oct 2023 – 31 Mar 2025 | 183 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Allan Traugott Wehnert | Current | |
| CEO | Rasmus Christian Drewes Jensen | ||
| CEO | Allan Traugott Wehnert | ||
| Board | Henrik Rouf | Current | |
| Board | Peter Severin Bach | Current | |
| Board | Christian Torben Hill-Madsen | Current | |
| Board | Christian Torben Hill-Madsen | ||
| Board | Samia Sofie Kappe | ||
| Board | Allan Traugott Wehnert | ||
| Board | Christian Torben Hill-Madsen | ||
| Board | Samia Sofie Kappe | ||
| Board | Allan Traugott Wehnert | ||
| Board | Henrik Keller | ||
| Owner (100%) | Nordicus Partners Corporation | Current | |
| Owner (100%) | Alteral Therapeutics ApS | ||
| Owner (50%) | GK PARTNERS ApS | ||
| Owner (33%) | Alteral Therapeutics ApS | ||
| Owner (33%) | GK PARTNERS ApS | ||
| Owner (5%) | JE Pitzner Holding ApS | ||
| Owner (5%) | JE Pitzner Holding ApS | ||
| Owner (50%) | GK PARTNERS ApS | ||
| Owner (25%) | Alteral Therapeutics ApS | ||
| Owner (90%) | Nordicus Partners Corporation | ||
| Auditor | CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB | Current | |
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Founder | Alteral Therapeutics ApS | Current |
The CEOs' other companies
Allan Traugott Wehnert – 7 other companies, of which 1 bankrupt
- ANPARTSSELSKABET WEHNERT Bankrupt 6 May 1996
- Alteral Therapeutics ApS Active
- BIO-CONVERT A/S Active
- NEUROINNOVATECH ApS Active
- NP Bioinnovation A/S Active
- Novithera ApS Active
- Wehnert Holding ApS Active
Rasmus Christian Drewes Jensen – 2 other companies
- Alteral Therapeutics ApS Active
- Ydun ApS Active
Address history (5 moves)
| Vandtårnsvej 62A, 1. b, 2860 Søborg | |
| Vandtårnsvej 62A, 1. e, 2860 Søborg | |
| Dyrehavevej 3, st., 2930 Klampenborg | |
| Mesterlodden 3A, 1., 2820 Gentofte | |
| c/o Erhvervsstyrelsen, Dahlerups Pakhus, Langelinie Allé 17, 2100 København Ø | |
| Mesterlodden 3A, 1., 2820 Gentofte |
Former names
| Orocidin A/S | – now |
| Orodicin A/S | – |
Other companies at the same address
- AFF-HOLDING ApS Bankrupt
- Biites ApS Bankrupt
- Bøegh & Borch ApS Bankrupt
- Caresupport ApS Bankrupt
- Caresupport Danmark ApS Bankrupt
- DANSK RENGØRINGSTEKNIK ApS Bankrupt
- Digital Web Solutions ApS Bankrupt
- EPC - Laser ApS Bankrupt
- Ecoman ApS Bankrupt
- FREY SOFTWARE ApS Bankrupt
- GPSP Denmark ApS Bankrupt
- Gydevang Holding ApS Bankrupt
- International Security Company IVS Bankrupt
- KURSUSHUSET ApS Bankrupt
- MM Budget ApS Bankrupt
- O.F Holding IVS Bankrupt
- SafeCloud ApS Bankrupt
- Satmobility ApS Bankrupt
- Servereksperten ApS Bankrupt
- Tufekci Holding ApS Bankrupt
- VINTAGE CLOUD A/S Bankrupt
- 3 STEP IT A/S Active
- AALBORG FASTIGHETER INTRESSENTER ApS Opløst
- AC EJENDOMME A/S Opløst
- AC HJEMMEHJÆLP ApS Opløst
Similar companies in Gladsaxe
- Novithera ApS Søborg
- QuantBioRes A/S Søborg
- BioNordic A/S Søborg
- BIO-CONVERT A/S Søborg
- AGC Biologics A/S Søborg
- NOVO NORDISK A/S Bagsværd
- SERA-SCANDIA A/S Søborg
- PHARMAERO ApS Kongens Lyngby
Questions and answers about Orocidin A/S
Has Orocidin A/S gone bankrupt?
No, Orocidin A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Orocidin A/S?
Our model estimates a bankruptcy risk of 3.4% over the next 12 months (high risk), which is 2.4 times the average for Danish companies.
Who is the CEO of Orocidin A/S?
Allan Traugott Wehnert is the CEO of Orocidin A/S.
Who is the auditor of Orocidin A/S?
Orocidin A/S most recently used CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB.
When was Orocidin A/S founded?
Orocidin A/S was founded on 2 October 2023.
What is the equity of Orocidin A/S?
Equity was DKK 10.0m according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.